| Crystal structure of of PDE2-inhibitor complex | | homo-4-mer | 579-916 | 100 | 4×ZN; 4×MG; 4×1L6; |
|
| X-ray structure of PDE2A | | homo-2-mer | 223-900 | 100.0 | 2×ZN; 2×MG; |
|
| Crystal structure of human phosphodiesterase 2A in complex with 6-methyl-N-(1-(4-(trifluoromethoxy)… | | homo-2-mer | 579-918 | 100 | 3×MG; 2×ZN; 2×87R; |
|
| [1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors | | homo-2-mer | 579-917 | 100 | 2×ZN; 2×MG; 2×QOQ; |
|
| Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-m… | | homo-2-mer | 579-916 | 100 | 2×ZN; 3×MG; 2×9GA; |
|
| Crystal structure of PDE2 catalytic domain in complex with BAY60-7550 | | homo-2-mer | 579-916 | 100 | 2×ZN; 2×MG; 2×19F; |
|
| Crystal structure of PDE2 catalytic domain in space group P1 | | homo-2-mer | 579-916 | 100 | 2×ZN; 2×MG; |
|
| PDE2 in complex with compound 5 | | homo-2-mer | 581-916 | 100 | 2×ZN; 2×MG; 2×FKJ; 11×EDO; |
|
| PDE2 in complex with compound 7 | | homo-2-mer | 581-916 | 100 | 2×ZN; 2×MG; 8×EDO; 2×FKV; |
|
| PDE2 in complex with compound 7 | | homo-2-mer | 581-916 | 100 | 2×ZN; 2×MG; 2×FKG; 3×EDO; |
|
| Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-m… | | homo-2-mer | 583-916 | 100 | 2×ZN; 2×MG; 2×9GJ; |
|
| PDE2 in complex with molecule 5 | | monomer | 580-919 | 100 | 1×MG; 1×ZN; 1×C6Z; 2×GOL; 1×SO4; 1×NA; |
|
| The Crystal Structure of the Phosphodiesterase 2A Catalytic Domain | | monomer | 576-915 | 99.41 | 1×ZN; 1×MG; 1×PO4; |
|
| Crystal Structure of human PDE2a in complex with (5S)-1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difl… | | monomer | 579-918 | 100 | 1×7OJ; 1×ZN; 1×MG; |
|
| PDE2a catalytic domain in complex with a brain penetrant inhibitor | | monomer | 579-918 | 100 | 1×788; 1×ZN; 1×MG; |
|
| Crystal structure of human phosphodiesterase 2A with 1-(2-chlorophenyl)-N,4-dimethyl-[1,2,4]triazol… | | monomer | 579-917 | 100 | 1×EOG; 1×ZN; 1×MG; |
|
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3,4-difluorophenyl)carbonyl]-3,… | | monomer | 579-917 | 100 | 1×7P4; 1×ZN; 1×MG; |
|
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-bromo-4-fluorophenyl)carbonyl… | | monomer | 579-917 | 100 | 1×7OJ; 1×ZN; 1×MG; |
|
| Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-methoxy-phenyl)-N-isobutyl-4-met… | | monomer | 579-917 | 100 | 1×EP7; 1×ZN; 1×MG; |
|
| Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chlorophenyl)-4-methyl-[1… | | monomer | 579-917 | 100 | 1×EOJ; 1×ZN; 1×MG; |
|
| Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-isobutoxy-phenyl)-N,4-dimethyl-[… | | monomer | 579-917 | 100 | 1×EOS; 1×ZN; 1×MG; |
|
| Crystal structure of human phosphodiesterase 2A with 1-(5-tert-butoxy-2-chloro-phenyl)-N-isobutyl-4… | | monomer | 579-917 | 100 | 1×EPV; 1×ZN; 1×MG; |
|
| PDE2a catalytic domain in complex with a brain penetrant inhibitor | | monomer | 579-917 | 100 | 1×ZN; 1×Q2T; 1×MG; |
|
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-chloro-4-fluorophenyl)carbony… | | monomer | 579-917 | 100 | 1×7OY; 1×ZN; 1×MG; |
|
| PDE2 catalytic domain complexed with inhibitors | | monomer | 579-917 | 100 | 1×7Y4; 1×ZN; 1×MG; |
|
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluoro-3-iodophe… | | monomer | 579-916 | 100 | 1×7OV; 1×ZN; 1×MG; |
|
| hPDE2A catalytic domain complexed with IBMX | | monomer | 579-916 | 100 | 1×ZN; 1×MG; 1×IBM; |
|
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluorophenyl)car… | | monomer | 579-916 | 100 | 1×7OP; 1×ZN; 1×MG; |
|
| Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl… | | monomer | 579-916 | 100 | 1×EOY; 1×ZN; 1×MG; |
|
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 3-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-… | | monomer | 579-916 | 100 | 1×7OG; 1×ZN; 1×MG; |
|
| CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX with [1,2,4]triazolo[1,5-a]pyrimidin-7-y… | | monomer | 579-916 | 100 | 1×7OM; 1×ZN; 1×MG; |
|
| PDE2 catalytic domain complexed with inhibitors | | monomer | 579-916 | 100 | 1×19F; 1×ZN; 1×MG; |
|
| PDE2 catalytic domain complexed with inhibitors | | monomer | 579-916 | 100 | 1×7XV; 1×ZN; 1×MG; |
|
| PDE2 catalytic domain complexed with inhibitors | | monomer | 579-916 | 100 | 1×7XS; 1×ZN; 1×MG; |
|
| PDE2 catalytic domain complexed with inhibitors | | monomer | 579-916 | 100 | 1×ZN; 1×MG; 1×7Y1; |
|
| PDE2 complexed with 2-[6-fluoro-8-methylsulfonyl-9-[(1R)-1-[4-(trifluoromethyl)phenyl]ethyl]-1,2,3,… | | monomer | 579-916 | 100 | 1×DY1; 1×ZN; 1×MG; |
|
| Crystal structure of PDE2 in complex with complex 9 | | monomer | 582-916 | 100 | 1×ZN; 1×MG; 1×CZY; 2×EDO; |
|
| Crystal Structure of PDE2 in complex with compound 16 | | monomer | 582-916 | 100 | 1×ZN; 1×MG; 1×CZV; 1×EDO; |
|
| PDE2 in complex with compound 1 | | monomer | 582-916 | 100 | 1×ZN; 1×MG; 1×D07; |
|
| [1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2 Inhibitors | | monomer | 591-916 | 100.0 | 1×ZN; 1×MG; 1×QMZ; |
|
| Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous System | | monomer | 581-905 | 100 | 1×EH9; 1×ZN; 1×MG; |
|
| Catalytic domain of hPDE2A | | monomer | 588-901 | 100.0 | 1×ZN; |
|